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Herpes Simplex Virus Type 1 (HSV-1) can infect the nervous system, resulting in 
a disease known as herpes encephalitis (HSE).  Herpes encephalitis affects thousands of 
people each year; many cases are fatal or permanently debilitating.  Approximately two 
thousand known cases occur in the United States each year alone (Neuroland online 
source).  Acyclovir has been the drug of choice used to treat herpes encephalitis.  Even 
after the administration of acyclovir, permanent neurological damage and/or death often 
results.  Thousands of individuals would benefit by the discovery of drugs that are more 
effective at preventing lasting HSE damage and death.  Knowledge concerning HSE 
infection of the brain could be advanced with the development of co-culture systems that 
allow for the study of one specific cell type or a subpopulation of cells during an active 
infection.       
Additional models are needed to test therapies against HSE.  The majority of 
models that currently exist are in-vivo or primary cell line models.  Even though many of 
these models can be used to mimic what actually occurs during herpes encephalitis 
infection in humans, these systems have several weaknesses.  The usage of in-vivo 
models requires a great deal of time, preparation, funding, and care by a veterinarian 
staff.  Primary cell lines can be difficult to isolate and maintain for long lengths of time in 
cell culture.   
 Unlike primary cell lines, continuous cell lines are able to be used for longer 




Type Culture Collection (ATCC) for a reasonable price.  Continuous cell lines are easy to 
culture and can be used in many different types of experiments.  The use of a continuous 
cell lines prevents animal suffering and death.   
 The purpose of this thesis was to determine if cell lines from a C3H murine strain 
can accurately mimic viral production that occurs during an actual HSV-1 infection in the 
central nervous system.  One cell line is a pure microglial cell line.   Three other cell 
lines, derived from P19 cells, were also tested.  One cell culture tested was a system 
composed of mixed brain cells such as neurons, astrocyte-like cells, and fibroblast-like 
cells.  Another culture evaluated contained only neuronal cells.  P19 cells were evaluated 
as well.  The results indicate that only the microglial and mixed cell cultures supported 
viral production that mirrors what occurs in animal models.   The neuronal cells not only 
failed to produce virus, but the neurons survived for less than twenty-four hours in 
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Background Literature  
HSV-1. Herpes Simplex Virus Type 1 (HSV-1) has an icosahedral nucleocapsid that is 
surrounded by an envelope covered with many tiny spikes that contain important viral 
glycoproteins (Voyles 2002).  In order for the brain to develop herpes simplex 
encephalitis (HSE), HSV-1 must first infect numerous cell types and successfully travel 
from the initial site of infection to the central nervous system (CNS).  HSV-1 must first 
infect epithelial cells that are present on the surface of the skin, the mouth, or the eye 
(Wang 2005). During attachment, the viral glycoprotein spikes first attach to the 
extracellular matrix surrounding the target epithelial cell.  Then, gB and gC (both spike 
glycoproteins) proceed to bind to the heparan sulfate on target epithelial cells.  Heparan 
sulfate is a large polysaccharide that extends out from the protein core of the epithelial 
cell.  After this virus has made contact with the cell through its heparan sulfate, other 
glycoproteins of the virus then proceed to attach to the cell.  Next, gD binds to a herpes 
entry mediator receptor.  This initiates the process of penetration (Voyles 2002).  After 
the epithelial cells have been infected, the virus can infect other epithelial cells as well as 
nearby neuronal cells.  
Neuronal Cells.  Neurons are cells of the nervous system that have the ability to carry 
electrical and chemical forms of communication from one part of the body to another 
part.  A neuron is composed of a cell body and processes that extend out from the cell 
body known as neurites.  Neurites can be either axons or dendrites.  Axons are 




end of the axon, there is a swelling present (known as the presynaptic terminal) where 
neurotransmitters are released to target cells (Purves 2004).  Neurotransmitters are 
chemical signals that are sent among neuronal cells.  Dendrites project out of the 
receiving neural cell bodies; dendritic postsynaptic terminals receive synaptic impulses or 
neurotransmitters from the axons of neighboring cells (Purves 2004).  Growth cones are 
specialized structures at the tip of axons that are responsible for exploring the external 
environment and guiding growth in a particular direction (Purves 2004).  Varicosities are 
identified as irregular shaped bulges in the axon that can be up to 8 times the diameter of 
the axon.  Varicosities are usually found at axon branch points (Saksena 2006).   
HSV-1 Infection of Peripheral Nerve Tissue.  This virus initially infects surface 
epithelial cells that are part of a mucosal membrane, like the mouth.  After infecting the 
surface epithelial cells, HSV-1 spreads to the axon fibers of peripheral nerves that are 
responsible for innervating the surrounding tissue.  Recent published data suggests that 
HSV-1 virions must bind to a series of receptors in order to attach to and fully penetrate 
neurons.  It is believed that HSV-1 glycoproteins gC and/or gB must bind heparan 
sulfate; gD is believed to bind nectin-1 (Immergluck 1998; Richart 2003).  However, 
other receptors, necessary for viral attachment and penetration, may also exist.   
In the synapse region, neurons have two main junctions with distinct functions.  
The junctions are known as synaptic and puncta adherentia junctions.  Both junction 
types are potential sites for viral penetration.  Puncta adherentia junctions are adhesion 
sites between neural axons and their targets.  Puncta adherentia junctions are formed by 
adhesion molecules known as nectins.  Some nectins are receptors for HSV-1 gD.  There 
are four types of nectins: nectin-1, nectin-2, nectin-3, and nectin-4.  The extracellular 




transmembrane region and then a cytoplasmic region.  The cytoplasmic region binds to 
afadin.  Afadin is a binding protein that connects the nectins to the actin cytoskeleton of 
the cell (Takai 2003).  Nectin-1 extends out from the presynaptic side, and Nectin-3 
extends out from the postsynaptic side at a synapse.  Nectin-1 and Nectin-3 form a 
hetero-trans-dimer to make the adhesion complete (Takai 2003).  Studies have shown that 
nectin-1 is the primary receptor that HSV-1 gD binds to when infecting neurons (Richart 
2003).  However, additional HSV-1 binding receptors on puncta adherentia or synaptic 
junctions cannot be ruled out at this time.  Some clinical strains of HSV-1, responsible 
for causing herpes encephalitis, have gD molecules that are capable of binding to nectin-2 
(Krummenacher 2004).   
In one study, transmission electron microscopy was used to study in-vitro HSV-1 
infection in neurons using human fetal dorsal root ganglion.  The dorsal root ganglion is a 
component of the PNS.  Special attention was paid to the following processes:  
attachment, penetration, and release.  In order to study attachment and penetration, the 
neurons were first infected with HSV-1 virus.  Then, these neurons were fixed and 
processed for electron microscopy at 90 minutes post infection.  Enveloped viral capsids 
were attached to the outside of the axon.  Unenveloped virions were seen in the interior 
of the axon.  However, partially enveloped capsids were not present, nor were enveloped 
capsids present inside the axon (Saksena 2006).  The absence of enveloped capsids inside 
the axon support entry by fusion, rather than entry by endocytosis.  Endocytosis would 
most likely result in the presence of enveloped capsids inside the axon (Saksena 2006).   
After the virus has successful penetrated the neuron, the virus then makes its way 
to the neuronal cell body where the viral DNA can reside latent in the nucleus.  The virus 




experiment, infected neurons were observed with an electron microscope.  This study 
determined that it took between 19 and 24 hours after infection for de novo synthesized 
virus to enter the axon.   The exact nature and location of viral release has not been fully 
determined at this time.  Some investigators have noted the presence of enveloped HSV-1 
capsids in the proximal area of the axon near the cell body.  Some have hypothesized that 
this could be a potential area where the virus is released.   
New evidence is emerging that may indicate other potential sites of viral release.  
Strong evidence that viral release occurs at axon terminals has recently been published by 
one group of researchers.  Unenveloped viral capsids have been observed in the middle of 
axons.  Unenveloped HSV-1 capsids were also observed in areas between the growth 
cones and varicosities.  Enveloped, unenveloped, and partially enveloped virions were 
identified in growth cones and varicosities of neurons (Saksena 2006).  Confocal 
microscopy was used to indicate where VP5 (a capsid protein), UL37 (a tegument 
protein), and gG (an envelope glycoprotein) were expressed in the axon.  Although 
staining for all three was present throughout the entire axon, colocalization of all three 
proteins was mainly detected in the varicosities and growth cones of terminal axons.  
Thus, the terminal regions of axons may be likely sites for viral release (Saksena 2006).   
The area of the cell body and the areas of proximal axons cannot be excluded as 
sites for viral release since enveloped capsids have been located in these regions as well.  
These factors have led some scientists to the conclusion that there are potentially two 
main sites where viral egress occurs.  One theory is that enveloped HSV-1 capsids might 
be released from areas of the cell body or proximal axon.  There may also exist a 




axons.  These unenveloped capsids travel to the growth cones and varicosities were they 
are enveloped and released (Saksena 2006).       
HSV-1 Infection of the CNS. Once the virus travels to the brain through peripheral 
neural pathways, HSV-1 is able to infect not only neurons, but also microglial cells, 
astrocytes, and oligodendrocytes (Immergluck 1998).  Microglial cells, astrocytes, and 
oligodendrocytes are three types of neuroglial cells that are present in the CNS.  
Astrocytes play a key role in maintaining a proper chemical environment in order to 
allow neuronal signaling.  Oligodendrocytes are responsible for myelinating the axons of 
neurons.  Microglial cells are considered to be macrophage cells by many scientists; 
however, some scientific communities still consider them to be distinct from macrophage 
cells.  They are the scavengers of the CNS; they remove unwanted debris.  During 
infection, these cells are able to secrete signaling molecules like cytokines (Purves 2004).  
In one study, many of these different cell types showed variable immunoreactivity to 
nectin-1 (Guzman 2006).  At this time, it is not clear if nectin-1 is the primary receptor 
used by HSV-1 to infect these cells.  
Vahlne et al. used cell fractions harvested from brains to study the amount of 
virus that was absorbed upon infection.   The cell fractions were prepared from the 
following CNS cell types:  neurons, astrocytes, and synaptosomes (synaptic regions of 
neurons).  Cells from rats, rabbits, and monkeys were first tested.   HSV-1 was absorbed 
by astrocytes and synaptosomes.  Synaptosomes absorbed a greater percentage of virus 
than did astrocytes.  The neural cell bodies were largely unsuccessful at absorbing virus.  
HSV-1 was more readily absorbed than HSV-2.  A similar experiment was conducted 
using the same types of cells from mice.  Analogous results were found, except that 




tissue, both synaptosomes and astrocytes absorbed HSV-1 virus.  However, 
synaptosomes absorbed more virus than astrocytes.  Neural cell bodies were unsuccessful 
at absorbing a majority of the virus.  Even though the human cells were able to absorb 
HSV-1, very little HSV-2 was absorbed.  The results from human sources were similar to 
the results obtained with the rat, rabbit, and monkey cells (Vahlne 1980).   
Immune Response to HSV-1 in the CNS. Once infection in the CNS occurs, microglia 
and astrocytes are believed to form an active immune response with cells that migrate 
into the CNS during times of infection.  The cells that migrate into the CNS include:  
lymphocytes, monocytes, and neutrophils.  CD8+ T-lymphocytes act to decrease 
virulence and spread of the virus through nonlytic methods, involving cytokines.  
Microglia are producers of chemokines that attract the lymphocytes to sites of infection 
in the CNS.  Microglia are believed to be the primary producers of cytokines in the CNS 
(Lokensgard 2001).   
During an active infection, CNS cells also differ in the quantity of virus produced 
by each cell type.  When infected, microglia initially produce only a limited amount of 
virus.  The production of virus rapidly declines in these cells as time passes.  Astrocytes 
and neurons are the main producers of virus during an active infection (Lokensgard 
2001).  A cell culture of human oligodendrocytes, infected with HSV-1, produced a large 
amount of virus; virus production increased with time (Bello-Morales 2005).   
Clinical Aspects of HSV-1 Infection in the CNS.  HSV-1 is capable of causing serious 
and lethal damage to the central nervous system.  HSE is one of the main causes of acute 
sporadic encephalitis in both adults and children (Tyler 2004).  Neonatal HSV-1 infection 




neonatal herpes infections are caused by HSV-2.  However, thirty percent are caused by 
HSV-1 (Burgos 2006). 
HSV-1 infections in the CNS have caused brainstem encephalitis, myelitis, and 
localized or diffuse HSE infections throughout the brain (Bovin 2004).  Patients can be 
grouped into having localized or diffuse HSE.  Localized HSE is more common than 
diffuse HSE.  Localized disease causes weakness, problems with the sensory system, 
aphasia, visual field defects, cranial nerve palsies, and/or abnormalities present on 
neuroimaging studies.  Diffuse disease causes patients to experience changes in 
personality and/or decreases in levels of consciousness.  Abnormalities, caused by diffuse 
HSE, are not detected with neuroimaging equipment.  Therefore, this form of infection 
can be harder to recognize (Tyler 2004). 
Polymerase chain reaction (PCR) of cerebral spinal fluid (CSF) is the primary 
diagnostic tool used for detecting the presence of HSV-1 in the CNS.  Magnetic 
Resonance Imaging (MRI) is used to locate apparent abnormalities in the brain during a 
HSE infection.  When localized HSE is present, MRIs often find edema and necrosis 
occurring in the temporal lobe region (Tyler 2004).  Upon diagnosis of HSE or when 
HSE is suspected, patients receive intravenous acyclovir (10 mg every 8 hrs for 14-21 
days).  The use of this drug has reduced mortality from approximately 70% to 28%.  In 
most cases, this drug causes a severe decline in the amount of PCR-positive cases within 
two weeks.  The treatment outcome is influenced by the following variables:  age, level 
of consciousness when treatment was started, duration of the HSE infection, and viral 
load at the time treatment was started.  Unfortunately, relapses can occur after acyclovir 
therapy.  When relapse occurs, PCR is again performed on CSF specimens from the 




immune-mediated encephalomyelitis which can cause demyelination of the neurons.  If 
virus is detected in CSF, then relapse is most likely from an active HSE infection (Tyler 
2004). 
Individuals who do recover are often severely impaired even if appropriate 
antivirals are administered (Tyler 2004).  Since harmful viral production is a critical 
component of pathogenesis resulting from an active infection, it logically follows that 
preventing widespread viral production would reduce the severity of the symptoms 
caused by an active HSV-1 infection.  Acyclovir is currently the drug of choice that is 
used to combat HSV-1 infection in the CNS.  However with the emergence of drug 
resistance in viruses, more anti-HSV drugs and therapies need to be developed.   Better 
drugs need to be developed that reduce viral load more significantly than acyclovir and 
that prevent serious sequel from occurring.  It would also be beneficial to have models 
that allow that effects of active infection to be studied using one specific cell type or a 
specific subpopulation of cells. 
Models used to study HSV-1 Infection.  Several models have been developed to study 
HSV-1 infection.  The majority of models are in-vivo or primary cell line models.  Even 
though many of these models can be used to mimic what actually occurs during herpes 
encephalitis infection in humans, these systems have weaknesses.  The usage of in-vivo 
models requires a great deal of time, preparation, funding, and care by a veterinary staff.  
When an animal is infected with HSV-1, the animal may experience pain and suffering.  
An infected animal is killed by the termination of the experiment.  Difficulties may also 
emerge when trying to use primary cell lines to study the effects of an active HSV-1 
infection.  A great deal of work is generally required to isolate specific cells from an 




contamination from other cell types or harmful microbes.  Many primary cell lines can 
only be maintained for a short period of time.  After a primary cell line is no longer 
viable, additional animals are used to provide additional cells.   
Unlike primary cell lines, continuous cell lines are able to be used for longer 
periods of time.  Many can be easily purchased from cell banks such as the American 
Type Culture Collection (ATCC) for a reasonable price.  Continuous cells lines are easy 
to culture and can be used in many different types of experiments.  They can be easily 
stored and used numerous times.  Continuous cell lines are not associated with the costs 
involved with maintaining and caring for animals used in in-vivo experiments or the 
continuous harvesting of primary cells.  
C3H murine continuous cell lines are available that are either cells from the 
central nervous system or cells that can be induced to differentiate into cells of the central 
nervous system.  The purpose of this research is to determine if several CNS cell cultures 
derived from C3H mice can be effective models to study HSV-1 production during an 
active infection.  Previous research has used both in-vivo models and in-vitro models to 
study viral production during an active HSV-1 infection.  In this thesis, C3H cell lines are 
evaluated based on viral production.  Both in-vivo and in-vitro experiments have 
demonstrated that neurons and astrocytes are capable of producing virus.  Nonproductive 
infection is usually apparent in HSV-1 infected microglia. 
 Lokensgard and colleagues conducted experiments on primary cell cultures from 
human fetuses.  The three cell cultures that were tested were: a cell culture comprised of 
neurons and 10% neuroglia, one of astrocytes, and one of microglial cells.  HSV-1 virus 
was produced by the cultures composed primarily of neurons and astrocytes.  Microglial 




nonproductive (Lokensgard 2001).  Completely formed virus has been located in the 
astrocytes and neurons of autopsied humans and animals who died due to herpes 
encephalitis infections (Landolfi 2005; Yamada 2003; Weissenbock 1997).   
Frye infected C3H mice with 1x106 pfu/eye of HSV-1, strain 17+.  The virus 
spread to the brain.  The brain was aseptically removed from mice at 2, 4, 6, and 10 days 
post infection.  The brains were then homogenized and afterwards the remaining cellular 
debris was removed through centrifugation.  Plaque assays were then performed on the 
supernatant fluids in order to determine viral titer.  Viral titer started to increase around 
Day 6 post infection.  On day 10 post infection, the viral titer reached the maximum level 
(23 pfu/ml) (Frye 2001).   
One purpose of these experiments was to create a HSV-1 cell culture system that 
can be used as an effective model to test anti-virals that are designed to decrease viral 
production.  Another purpose of these experiments was to create models of 
subpopulations of CNS cells that could be studied during active infection.  These models 
must mimic what actually occurs in-vivo.  These models must respond to anti-virals the 
same way that these cell types would in-vivo.  For example, acyclovir, the drug of choice 
for treating herpes encephalitis, decreases viral production in both in-vivo and in-vitro 
models.  In order for these cell culture models to be effective, acyclovir should also 
decrease viral production in these cell cultures.   
Hypothesis.  The hypothesis of this study is that CNS cell lines from the C3H mouse can 
be used as models to study HSV-1 viral production by different cell types, namely 
undifferentiated P19 cells, neurons, microglial cells, and a mixed cell population 








Materials and Methods 
Over twenty years ago, McBurney (Jones-Villeneuve 1982) developed the P19 
cell line (ATCC CRL-1825).  This cell line is derived from a C3H murine embryonal 
teratocarcinoma cell.  P19 cells are stem cells that can differentiate into a broad range of 
other cell types after exposure to certain chemicals.  Upon exposure to dimethyl 
sulphoxide (DMSO), the P19 cells rapidly differentiate into cardiac and skeletal muscle 
cells.  When these same cells are exposed to retinoic acid, P19 cells rapidly develop into 
neuronal and neuroglial cells of the brain.  In previous research, P19 cells were exposed 
to retinoic acid and some of the subpopulations stained positive to either Neurofilament 
160 or GFAP.  Cells with neuronal morphology stained positive for Neurofilament 160 
(used to indicate the presence of neurons).  Many of the cells stained positive for Glial 
Fibrillar Acidic Protein (GFAP).  Astrocytes are the only known cells that express GFAP 
(Jones-Villeneuve 1982). 
The overall intent of this experiment was to quantify viral production within the 
first 48 hours after infection.  Consequently, my experiment included separate analyses of 
undifferentiated P19 cells, mixed brain cells, microglial, and neuronal cells.  In this study, 
C3H embryonal teratocarcinoma cells (P19) were exposed to retinoic acid.  Retinoic acid 
changed the P19 cells into a mixed population of brain cells (Jones-Villeneuve 1982).  
From this cell culture mixture, neuronal cells (post mitotic cells) were isolated by using 




isolated neuronal cells comprise three of the four cell cultures studied.  A different C3H 
microglial cell line (ATCC CRL-2467) was also studied.   
 Determining viral production in the four cell lines involved several stages.  The 
stages involved infecting different CNS cell types with HSV-1, harvesting the 
supernatant fluids surrounding the cells at specific time points, and analyzing the virus 
titer.  The next stage of the experiment was plaque assay.  The purpose of this part of the 
experiment was to quantitate the amount of virus produced by the various cell types at 
specific times after infection.  Another experiment was conducted to determine if the 
cells of the mixed brain cell culture were capable of de novo synthesis.   
 
 
   
   
Figure 1.Bundles of neuronal cell bodies lie upon astrocyte-like cells.  The arrow points to a bundle of 
neuronal cells with processes extending out from the cell bodies.  The measurement bar represents 50µm. 
   
Preparation of cells prior to infection.  The different cell types were placed in the wells 
of twelve well plates prior to being infected with 1 MOI of virus.  The cells were 
suspended in the media noted in Table 1 and Table 2.   When testing the microglial cells 
and the P19 cells, 2.5x105 cells were placed in each well and incubated overnight before 
being infected with 1 Multiplicity of Infection (MOI).  MOI is defined as infectious viral 




In order to prepare the mixed brain cells, P19 cells were first incubated in 100 x 
15 mm petri dishes containing media with 5x10-7M of retinoic acid for a period of four 
days.  The media was replenished every two days.  After the four day incubation period, 
the cell aggregates were removed and resuspended in fresh media.  A cell count was 
performed, and 5x105 cells were added to each well of the 12 well plate.  The media was 
changed every 2 to 3 days as needed.  After six days had elapsed, a cell count was taken 
of four wells using a hemocytometer.  The average cell count of the four wells was then 
determined.  This number was taken as the approximate number of cells in each well of 
the plate.  Then, 1 MOI of virus was added to three wells.   
  In order to prepare the isolated neuronal cells, P19 cells were first incubated in 
petri dishes containing media with 5x10-7M of retinoic acid for a period of four days.  
The cells were given fresh media every two days.  After four days, the cell aggregates 
were collected.  A cell count was performed using a hemocytometer, and 1x106 cells 
were added to each well of the 12 well plate.  After a cell count had been taken of the 
cells in media, 1x106 cells were placed into each well of a laminin coated 12-well plate.  
Each well contained at least 1m of media.  The cells were then incubated overnight.  The 
next day, old media was removed, and Neuralbasal media containing B-27 supplement, 
5µg/ml of cytosine arabinoside (ArcC), and 0.5M L-glutamine were added.  There was at 
least 1ml of media in each well.   The media was changed every 2 to 4 days and replaced 
with fresh media.  Total incubation time with the cytosine arabinoside was approximately 
6 days.  After six days, the cells were switched to regular Neuralbasal media with just the 
B-27 supplement and L-glutamine.  The cells were exposed to the new media overnight 
before being infected with virus.  The next morning, a cell count was taken of four wells.  




number of cells present in each well.  Then, three of the wells were infected with 1 MOI 
of virus.     
Table 1.  Media used for culturing the P19 Cells 
Cell Types Undifferentiated 
P19 Cells  and 
Differentiated 
P19 cells 












































Table 2.  Media used for culturing Vero and Microglial Cells 
Cell Type Vero Cells Microglial Cells 
Media Used* Dulbeccos Modified Essential 
Media (DMEM), 10% CS 
DMEM, 10%CS, 20% LADMAC 
conditioned media 
 
*Based on previous research, all derivatives of P19 cells were exposed to 1xGentamycin Sulfate solution.  
Microglial cells and Vero cells were exposed to 1xPen-Strep Solution.  All cells were incubated in an 
incubator at 37ºC, 5% CO2. 
 
Table 3.  Procedures for Preparing Isolated Neuronal Cells 





cells with ArcC 
and serum-free 
Neuralbasal 
media for 6 
days 
Infect the cells 
with 1 MOI of 
HSV-1 virus 
Purpose Allows the 
cells to 
differentiate 
into a mixed 







media will kill 
all of the cells, 
except for the 
neurons.  This 
procedure 
allows for the 
isolation of the 
neurons. 
The virus will 
be allowed to 





Infectivity Assays.  Each experiment was performed in triplicate.  Each well was 
infected with approximately 1 MOI of HSV-1, 17+ strain.   Supernatant fluids from three 
wells were harvested at the following time points post infection:  6 hrs, 12 hrs, 24 hrs, 36 
hrs, and 48 hrs.  After supernatant fluids had been collected from each well, 2 mls of 
fresh media were added back to each of the wells.    After the supernatant fluids were 
collected, they were centrifuged and filtered with .45µm sterile filters to remove any 
extraneous cell debris.  The filters allowed virus to pass through.  All supernatant fluid 
samples were titered using a plaque assay.  
Plaque Assay Protocol.  In each well of a 12-well plate, 1.25 million Vero cells were 
placed and allowed to attach overnight.  The Vero cells were suspended in MEM with 5% 
CS.  The entire plate was incubated until confluent monolayers formed in each of the 
wells.  Then, ten fold dilutions were made of the supernatant fluids from the infected 
cells.  Each well was rinsed with serum-free MEM.  The dilutions were added to separate 
wells in the 12-well plates.  In each well, 250µl of virus infected media from each 
dilution was placed in each well of the 12 well plate.  The plate included two wells that 
did not contain any virus.  Those wells served as controls.  The plate was then incubated 
for one hour.  During this time, the plate was occasionally shaken.  After incubation, the 
supernatant fluid dilutions were removed from the different wells.  Then, 2 mls of 2% 
methyl cellulose were added to each well.  The plate was incubated for 4-5 days.  Then 1 
ml of formalin solution was added to each well.  This solution was left in the wells for 30 
minutes to fix the cells and kill virus.  After the appropriate incubation period, the 
formalin solution was aspirated, and the wells were gently rinsed with tap water if large 
amounts of methylcellulose remained.  Next, 1 ml of crystal violet dye was added to each 




were rinsed with tap water.  The plate was turned upside down on a paper towel in the 
virus hood and left for 1-2 days until the bottoms of the wells were sufficiently dry.  
Next, visible distinguishable plaques were counted.  Then plaque forming units (PFUs) 
were determined for each well using the formula below.  All the PFUs for each counted 
well were averaged together to generate the overall PFU number assigned to each plate.   
Table 4.  Illustration of a Plaque Assay Setup 
No virus/control No virus/control 10-4 dilution 10-4 dilution 
10-3 dilution  10-3 dilution 10-2 dilution  10-2 dilution 
10-1 dilution 10-1 dilution no dilution no dilution 
 
The formula used to determine pfu from plaque assays is (plaque number x 
reciprocal dilution x reciprocal volume in ml).  An example of this would be if 40 
plaques were counted from one well infected with a .25 ml of a 10-5 virus dilution, the 
PFU would be determined 40x(105)x4=1.6x108 pfu/ml. 
Acyclovir Experiment.  The purpose of this experiment was to determine if de novo 
synthesis was occurring in the mixed brain cells.  The addition of acyclovir to many types 
of cells infected with HSV prevents de novo synthesis.  If titers from wells with acyclovir 
and wells without acyclovir were similar, then that would have indicated that de novo 
synthesis was not taking place.  A difference in viral titer between wells with acyclovir 
and wells without acyclovir would indicate that de novo synthesis was occurring.   
 P19 cells were first differentiated with retinoic acid as described in the previous 
experiment above.  Then 5x105 cells were placed into each well of a 12-well plate and 
allowed to mature for a period of 6 days.  After the six day period of incubation, the cell 
count from four of the wells was determined as explained in the previous section.  The 
average of the four wells was taken as the average cell count in each well.  Three wells 




with virus.  A set of three wells were not pre-incubated with acyclovir before infection.  
Each set was infected with 1 MOI of virus for one hour.  Then each well was rinsed four 
times with serum free medium to remove any remaining input virus that had not been 
absorbed by the cells.  Then α-MEM media that contained 5% CS and 100µM of 
acyclovir was added back to the wells that had been previously incubated with acyclovir.  
To the cells that had not been previously treated with acyclovir, only α-MEM with 5% 
CS was added.  Each well was incubated with a total of 2 mls of media.  The infected 
cells were observed every twelve hours.  The supernatant fluids from each well were 
harvested at 36 and 72 hours post infection.  After the supernatant fluids were harvested 
at 36 hours post infection, the same specific type of media was placed back into each of 
the wells.  The experiment was terminated at 72 hours post infection.   
Immunohistochemistry.  The presence of neuronal cells was verified by the use of 
immunohistochemistry.  Immunohistochemistry was carried out using Neurofilament 160 
(Mice IgG) as the primary antibody.   A Rabbit FAB:HRP antibody was used as the 
secondary antibody.  The substrate used was black DAB (3,3-diaminobenzidine). 
Differentiated P19 cells were plated on glass slides for at least six days.  The 
culture media was aspirated off the cells.  The cells were rinsed with PBS for 
approximately five minutes.  After the cells had been rinsed, they were fixed with fresh 
acetone for a period of 2-4 minutes.  The slides were removed from the acetone and 
washed at least three times with PBS and .2% Tween.  Unspecific binding on the tissue 
was prevented by adding rabbit serum for 40 minutes, followed by a treatment of 
blocking buffer (PBS with just .001 grams of BSA).  The primary antibody (Chemicon 
Neurofilament 160) was added to the slides overnight.  The slides were placed inside a 




overnight, the slides were rinsed at least three times with PBS/Tween.  Next, the F(ab)2 
rabbit anti mouse IgG: HRP secondary antibody (Serotec STAR13B) was added to the 
slides and left undisturbed for a period of 30 minutes in a humidity chamber.  The slides 
were rinsed at least three times with PBS/Tween.  The slides were then placed back in the 
humidity chamber, and DAB (Vector Labs) was added for fifteen minutes.  After the 
DAB incubation period, the specimens were rinsed in tap water for five minutes.  The 
slides were then counter-stained with Nuclear Red and then dehydrated.  After counter-
staining had occurred, the cells were mounted with permount.  Some differentiated P19 
cells on slides were prepared the same way as described above; however, they were not 
exposed to antibody and were counter-stained with eosin and hemotoxylin. 
 
Figure 2.In this picture, the neurons are staining positive to Chemicon  Neurofilament 160.  The 
measurement bar represents 50µm. 
 
 
Figure 3.ControlExposed to the same conditions as the stained cells above; however, primary antibody 









Results & Discussion 
 
 The main purpose of these sets of experiments was to determine whether 
the four cell types tested were able to produce virus once infected with 1 MOI of HSV-1 
virus.  The amount of virus produced by each cell culture was determined by performing 
plaque assays on supernatant fluids taken from the infected cells.  The hypothesis of this 
study is that CNS cell lines from the C3H mouse can be used as models to study HSV-1 
viral production by different cell types, namely neurons, microglial cells, and a mixed 
cell population containing neurons, astrocyte-like cells, and fibroblast-like cells during a 
an active HSV-1 infection.   P19 cells, the progenitor of the mixed brain cell culture and 
the isolated neuronal culture, was test as well.  Only the mixed brain cell culture and the 
microglia cell culture supported the hypothesis.     
 P19 Cells 
Plaque Assay Results 
 The highest number of viral plaques was detected at the 6 hour time point post 
infection.  However, this was most likely residual virus left over from the input virus.  
After that specific time point, the viral titer declined.  By the 48 hour time point, no virus 
was detected by the plaque assays.   
These cells were not active producers of virus.  The results were similar to the 
results obtained by John Bell et al.  John Bell and colleagues infected P19 cells with the 
HSV-1 KOS strain. The P19 cells synthesized viral TK (an early beta gene product), gD, 




few virion components were detected by electron microscopy.  This suggests that HSV-1 
replication is prevented at a late stage in the infectious cycle of the HSV-1 virus.  In this 
study, the supernatant fluid samples were collected at the 24 hour time point after 
infection with HSV-1, strain 17+.  By the 24 hour time point, the media in the cell culture 
contained no viable cells and a great deal of cellular debris was present.  This is 
comparable to the observation by Bell et al. who noted complete CPE of P19 cells 
infected with the HSV-1 KOS strain at 20 hours post infection (Bell 1987).  Many viruses 
that have enhancers that regulate gene expression have not been very successful in 
carrying out a productive infection in P19 cells.  Therefore, viruses like HSV-1 that have 
enhancers may not be able to successfully replicate in embryonal carcinoma cells or other 



















    6 hrs             12 hrs               24 hrs           36 hrs            48 hrs
 
Figure 4.Illustrates the average viral titer present from infected P19 cell supernatant fluids at different 
periods post infection.  The error bar is the standard error of the mean.  The initial viral input was 2.5x105 
PFUs. 
 
Isolated Neuronal Cells 
 




Throughout this 48 hour assay, the viral titer declined.  By the 48 hour time point, 
virus was not detected in the plaque assays.  Due to the fact that the majority of the cells 
appeared to be dead at 12 hrs post infection and the viral titer declined, it is likely that 
these specific cells are not active producers of virus.  These cells were very sensitive to 
the pathogenic effects of the virus.  Because these cells were destroyed so quickly after 
infection, this particular cell culture would not serve as a good model to study latency or 
an active infection in neurons.  The quick demise of these cells after infection could 
indicate that other central nervous system cell types such as astrocytes, fibroblast-like 
cells, or other support cells must interact with neurons to allow these neurons to survive 
infection and to experience latency.  Because these neurons are derived from embryonal 
cell precursors and not more mature cells, these specific neurons may be ill equipped to 
survive an active infection.  The artificial environment that these neuronal cells were 

















    6 hrs             12 hrs               24 hrs          36 hrs             48 hrs           
 
Figure 5.  This chart illustrates the average viral titer from infected neuronal supernatant fluids at different 
times post infection.  The sample bar is the Standard Error of the Mean.  The viral input was 1.875x104 
PFUs. 
 





Plaque Assay  
 
 Throughout the 6 and 12 hour time points post infection, the viral titer decreased.  
However starting at the 24 hour time point post infection, the viral titer began to increase.  
The increase in viral titer continued until the experiment was terminated at the 48 hour 
time point after infection.  The virus that was present during the 6 and 12 hour time 
points was most likely residual virus that was left from the initial infection.  However, an 
increase in viral titer after the first 24 hour time point was noticed.  This increase was 
believed to be de novo synthesis.  
 After the virus attaches and penetrates the host cells, the eclipse period occurs.  
During the eclipse period, viral nucleic acids and viral proteins are being synthesized 
inside the cell.  At this point, the virus is not released into the extracellular media.  Once 
the virion particles have synthesized all of their needed components and are mature, then 
they are released to the outside where they can be harvested (Voyles 2002).  Between 12 
to 24 hours post infection, viral particles were released into the media outside of the 
infected cells.  Therefore, it is likely that the eclipse period in these cells lasted until 12 to 
24 hours post infection.  Viral production continued to increase throughout the remainder 























   6 hours           12 hours         24 hours         36 hours         48 hours
 
Figure 6.This bar graft represents the average HSV-1 titer for the supernatant fluids from the mixed brain 
cells taken at each time point.  The error bar is the Standard Error of the Mean (SEM).  The viral input was 
6.425x105 PFUs.  One way ANOVA was performed using Kruskal-Wallis One Way Analysis on Variance 
on Ranks р <.050. 
 
The most likely cell types present in this mixed cell culture are neurons, 
fibroblast-like cells, and astrocytes.  This experiment cannot determine the source of the 
virus production or if the cells present must interact with each other in order to produce 
virus.   Future experiments could possibly be performed to determine if each specific cell 
type in the mixed culture produces virus independently.  
A second experiment was implemented to confirm that de novo synthesis was 
indeed occurring in the mixed brain cell culture.  The amount of virus produced by the 
mixed brain cell culture was lower than the amount of initial input virus.  Therefore, 
another experiment was devised.  This experiment was accomplished by studying two 
sets of wells.  Three wells were only exposed to HSV-1; there was no substance added to 
impede de novo synthesis.  Acyclovir was added to three other wells.  Acyclovir is a 
potent anti-HSV-1 nucleoside analog that is incorporated into the growing strain of a 




and properly formed; therefore, de novo synthesis is greatly reduced.  A total of six wells 
were tested.  Wells A, B, and C were exposed to acyclovir 2.5 hours before infection and 
throughout the remainder of the experiment.  Wells D, E, and F were not exposed to 
acyclovir.   All wells were inoculated with 1 MOI of virus.  The results are shown in the 
table below.   
*Table 5.  Experiment to Determine the Presence of De Novo Synthesis 
Well Type 36hrs 72 hrs 
Well A 0.00E+00 0.00E+00
Well B 0.00E+00 0.00E+00
Well C 0.00E+00 0.00E+00
Well D 1.53E+04 1.13E+04
Well E 1.66E+04 8.67E+02
Well F 1.70E+04 9.22E+02
 
Legend 
Wells A, B, and C were exposed to acyclovir and HSV-1. 
Wells C, D, and E were exposed to only HSV-1. 
 
*One way ANOVA was performed using Kruskal-Wallis One Way Analysis on Variance on Ranks р 
<.050. 
  
 No virus was detected with plaque assays during the 36 and 72 hour time points 
post infection in the wells that were exposed to acyclovir before and during the 
experiment.  However, virus was detected in the supernatant fluids of the cells that were 
not exposed to acyclovir.  The greatest amount of virus production was seen at the 36 hr 
time point.  The amount of virus (1.63x104 PFUs) produced at 36 hrs in this experiment 
was slightly lower than the amount of virus (5.9x104 PFUs) produced by the previous 
experiment using mixed brain cells.  However, the amounts produced in each experiment 
are within the same log.  One of the supernatant fluids without acycovir had a much 
higher viral titer than the other two samples of supernatant fluids collected at 72 hours 
post infection.  This may have been due to the fact that the mixed brain cell cultures in 




produced the majority of virus and the components of one well had more of this specific 
cell type than the others did, the supernatant fluids collected from that well would most 
likely have a higher viral titer.   
 When the virus titers of the infected cells were compared with the virus titers 
from the cells exposed to acyclovir, it appears that acyclovir severely reduced the amount 
of de novo synthesis occurring in the infected cells.  This last experiment proved two 
important things.  First, it proved that de novo synthesis was occurring in the infected 
cells.  If the mixed cell culture was not able to manufacture virions during the 
experiment, then the virion levels would be the same in both sets of wells.  The last 
experiment also showed that this cell culture responded appropriately to acyclovir.  In the 
experiment, acyclovir reduced viral titer.  This is what occurs during an actual infection 
in-vivo.  Other anti-HSV-1 drugs should be tested with this system to see if the model 
reacts to them the same way as what actually takes place in-vivo. 
Microglia Cells 
Plaque Assay 
 The microglial cell culture showed a decrease in viral titer during the 6 and 12 
hour time points post infection.  During this time it is likely that the only virus present 
was remaining input virus.  Starting at the 24 hr time point, an increase in viral titer 
occurred.  However, this increase was slight.  The microglial cells were poor producers of 





















6 hours            12 hours          24 hours        36 hours        48 hours
 
 
Figure 7.This bar graft represents the average HSV-1 titer for the supernatant fluids from infected 
migroglial cells taken at each time point.  The error bar is the Standard Error of the Mean (SEM).  The 
initial input was 2.5x105 PFUs. One way ANOVA was performed using Kruskal-Wallis One Way Analysis 
on Variance on Ranks р <.050. 
 
Assessment of Hypothesis and Future Research Suggestions 
 The only two models that support the hypothesis are the mixed brain cells and the 
microglial culture based on viral production.  Microglia are present in humans of all age 
groups.  However, the mixed culture is similar to only the human infantile stage of 
development or unmyelinated neurons in the adult brain.  The neurons present in this cell 
culture are not myelinated nor do they have oligodendrocytes.  The brain of an infant is 
mostly unmyelinated with only few oligodendrocytes.  The mixed brain cells could 
possibly serve to model neural and neuralglial cells present in the brain of an infant (Arey 
1974).   
 An adult brain has myelinated axons and oligodendrocytes present.  This means 
that the mixed culture does not truly model the brain cells of an adult; unless a 




that are not myelinated and that are without oligodendrocytes, then this model may be 
appropriate (Arey 1974).   
 Previous in-vitro and in-vivo research has shown that neurons and astrocytes are 
producers of virus.  The mixed brain cells produced virus during this experiment.  
However, additional tests are needed to determine which cell type/subgroups of cells are 
the true producers of the virus.  This could be accomplished by viewing infected cells 
with electron microscopy at different time periods post infection.  To date, the presence 
of neurons and astrocytes in the differentiated P19 culture has been verified with the use 
of immunohistochemistry and immunofluorescence (Jones-Villeneuve 1982).  However, 
the cells that are similar to fibroblast-like cells need to be fully identified.  Fibroblast 
cells are an integral part of the meninges which surrounds the brain.  The role of 
fibroblast cells during an active infection in the CNS has yet to be fully explored.   The 
exact nature of the fibroblast-like cells might also be determined by performing Real 
Time PCR on those cells and looking for mRNA that is produced only by fibroblast cells.   
 Lokensgard and colleagues showed that neurons and astrocytes were not the 
primary producers of cytokines during an actual infection.  In order to determine if the 
neuronal cells and the astrocytes in the mixed culture produce cytokines, the remaining 
frozen supernatant fluids need to be analyzed for cytokine production.  However, any 
cytokines produced by the fibroblast-like cells would also be detected.   
 Acyclovir has been shown to reduce virus load in animal experiments.  Acyclovir 
reduced the viral titer when given to the mixed brain cells before and after infection.  
Therefore, the brain cells responded in a similar manner to brain cells in-vivo.  However, 
it would also be beneficial to determine the effects of other antivirals on the mixed cell 




mirror what actually occurs in-vivo, then the mixed brain cells may be able to serve as a 
model to study active infection in brain cells. 
 The microglial cells were also tested.  They were not robust producers of virus.  
However, this mirrors what has been found in other research.  Several experiments need 
to be performed in order to determine if the C3H microglial cell culture can be used as an 
effective model to study the effects of HSV-1 infection.  It is crucial that the production 
of cytokines be examined in the supernatant fluids of infected cells.  The response of 
these microglial cells to anti-virals should also be determined and compared to in-vivo 
models.   Once this has been accomplished, one can better evaluate the use of this cell 
line to study HSV-1 infection.           
 Determining whether these cells are more effective models than in-vivo and 
primary cell in-vitro counterparts is also another important consideration when deciding 
if these cell cultures are to be effective models.  Disadvantages exist in the use of these 
cell cultures to either test anti-virals or to study in-vitro co-cultures.  There is no 
component in these models that mimics the blood brain barrier in the CNS.   The blood 
brain barrier of the CNS is the main barrier the separates neural tissue from the blood.  
This barrier is composed of special endothelial cells that surround CNS capillaries and 
prevent the majority of molecules from passing into neural tissue from the blood.  The 
astrocytes help to regulate the types and amounts of molecules that are allowed to pass 
into the neural tissue from the blood.  For example, they regulate the concentration of K+ 
ions in the neural tissue.  The blood brain barrier prevents many substances like 
antibiotics from entering the brain.  Even if a drug or a molecule can affect the brain 
during in-vitro conditions, it may not actually affect the neurons and neuroglia in the 




 The absence of other organs and cell types that are in the body may cause results 
to be different when comparing data from in-vitro experiments with in-vivo experiments.  
In order to be effective, some drugs must be metabolized by certain organs before they 
can act on a target area of the body.  It also follows that drugs that would normally be 
effective on an in-vitro system may not react the same way in-vivo when they are first 
modified by another organ.  These continuous cell cultures do not show significant harm 
that drugs or therapies could cause to organs outside the central nervous system. 
 Lymphocytes and macrophages are not present in these cell cultures.  Therefore, it 
would be impossible to determine what the full immune response would be during an 
active infection.  This could possibly be corrected by isolating lymphocytes and 
macrophages and adding them to these cell lines.   
 Even though there are disadvantages associated with these continuous culture cell 
lines, there are many advantages that are not present in in-vivo models and in-vitro 
models comprising of primary cells.  The absence of other cells such as the lymphocytes 
and macrophages allows for the study of the immune response between only a subset of 
cells.  This cannot be accomplished with whole animal in-vivo models.   
 In-vivo models are very expensive because there must be funding available to 
house, feed, care, and medically treat animals used in research.  The use of primary cells 
can accrue these types of costs to a lesser extent.  Primary cells can only be cultured for a 
certain length of time before new cells have to be harvested from other animals.  It also 
takes a great deal of time and equipment to extract the cells and prep them to be cultured.  
Continuous cells can initially be grown-up in media.  They can be grown and frozen 
down indefinitely in a short period of time.  The freezing down of stockpiles of 




 Both the microglial and the P19 cells (precursors of the mixed brain cells) can be 
easily purchased through American Type Culture Collection (ATCC).  This allows 
researches to perform and collaborate on research using cells from the same source.  
Even if researches use the same strain of a specific animal when conducting in-vivo or in-
vitro experiments, there may be some genetic variation present that could cause 
differences in data collected from different labs. 
 Unlike an actual in-vivo model, the process of infection can be continuously 
observed during an active infection using the C3H cell lines.  The infection process of an 
in-vivo system is studied by sacrificing animals at various time points and observing 
regions of interest.  In order to gain approval to use animals for in-vivo experiments or as 
the source of primary cells, researchers must first gain approval by using appropriate 
protocols and presenting compelling preliminary data.  No such approval process is 
needed when using continuous cells from a reputable cell bank.  In fact the results 
generated from experiments using these continuous cells could potentially be used as 
preliminary data that supports requests for experimentation using in-vivo animal models.  
Even though these two continuous cell lines have several limitations which would require 
testing to be performed using in-vivo models, these cell lines have characteristics 
analogous in-vivo CNS cells which could allow them to be used as models to study HSV-
1 infection.  However, before these cell lines can be used as models or in a co-culture 
system, the additional experiments mentioned above need to be completed.  











Raw Data for the Infectivity Assays 
 
P19 HSV-1 Viral Titer   
Plaque Assays Wells 
 
PFUs/Well
6hrs   
PA-(6A/6B) Well A 6.13E+03 
PB-(6A/6B) Well B 2.19E+03 
PC-6B Well C 1.60E+04 
Average Average 8.11E+03 
12hrs   
PA-12B Well A 1.44E+02 
PB-12B Well B 4.00E+02 
PC-12B Well C 2.40E+01 
Average Average 1.89E+02 
24 hrs   
PA-24CF Well A 0.00E+00 
PB-24A Well B 1.60E+01 
PC-
(24CF,24DF,24EF) Well C 0.00E+00 
Average Average 5.33E+00 
36 hrs   
PA-36DF Well A 0.00E+00 
PB-36A Well B 4.00E+02 
PC-36A Well C 3.20E+01 
Average Well D 1.44E+02 
48 hrs   
PA-48EF Well A 0.00E+00 
PB-48DF Well B 0.00E+00 
PC-48CF Well C 0.00E+00 
Average Average 0.00E+00 
Total Produced  8.45E+03 
 
Neuronal HSV-1 Viral Titer 
Plaque Assays Wells 
Total 
PFUs 
6hrs    
NA-(6A/6B) Well A 5.76E+02 
NB-(6A/6B) Well B 1.40E+02 
NC-(6A/6B) Well C 4.32E+02 
Average  3.83E+02 
12 hrs   
NA-(12A/12B) Well A 4.00E+00 
NB-12A Well B 0.00E+00 
NC-12A Well C 2.00E+01 
Average  8.00E+00 
24 hrs   




NB-24A Well B 0.00E+00 
NC-24A Well C 0.00E+00 
Average  0.00E+00 
36 hrs   
NA-36A Well A 0.00E+00 
NB-36A Well B 8.00E+00 
NC-36A Well C 0.00E+00 
Average  2.67E+00 
48 hrs   
NA-48B Well A 0.00E+00 
NB-48B Well B 0.00E+00 
NC-48A Well C 0.00E+00 
Average  0.00E+00 
Total Produced  3.93E+02 
 
Mixed Cell Culture HSV-1 Viral Titer 
Plaque Assay Wells 
Total 
PFUs 
6 hrs   
MA-6B Well A 7.20E+02 
MB-6B Well B 3.36E+03 
MC-6B Well C 1.52E+03 
Average  1.87E+03 
12 hrs   
MA-12A Well A 2.40E+02 
MB-12A Well B 9.60E+02 
MC-12A Well C 7.20E+02 
Average  6.40E+02 
24 hrs   
MA-
(24CF/24DF) Well A 4.20E+02 
MB-24CF Well B 7.28E+03 
MC-24BF  5.60E+03 
Average  4.43E+03 
36 hrs   
MA-36A  2.08E+04 
MB-36A  6.76E+04 
MC-36A  6.72E+04 
Average  5.19E+04 
48 hrs   
MA-(48A/48B)  1.54E+05 
MB-(48A/48B)  1.56E+05 
MC-48B  6.24E+04 
Average  1.24E+05 
Total Produced  1.83E+05 
   
 
Microglia HSV-1 Viral Titer 






6hrs   
MiA-(6A/6B) 8.35x103 8.35E+03 
MiB-6B 2.48x103 2.48E+03 
MiC-6B 3.84x103 3.84E+03 
Average  4.89E+03 
12 hrs   
MiA-(12A/12B) 2.82x102 2.82E+02 
MiB-(12A/12B) 1.76x102 1.76E+02 
MiC-(12A/12B) 1.8x102 1.80E+02 
Average  2.13E+02 
24 hrs   
MiA-(24A/24B) 1.33x103 1.33E+03 
MiB-(24A/24B) 1.36x103 1.36E+03 
MiC-(24A/24B) 2.66x103 2.66E+03 
Average  1.78E+03 
36 hrs   
MiA-36B 1.76x103 1.76E+03 
MiB-36B 1.76x103 1.76E+03 
MiC-36A 4x103 4.00E+03 
Average  2.51E+03 
48 hrs   
MiA-(48A/48B) 3.6x103 3.60E+03 
MiB 1.04x103 1.04E+03 
MiC-48B 1.28x104 1.28E+04 
Average  5.81E+03 
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